So, I don't work in biotech, but having seen technology with disruptive potential take off, I think there would be plenty of politics, testing, etc before switching over from any incumbent tech.
It takes a long time to realise, but having researched ADO, it looks like the right combo exists, so if there's no signing today or this month, it would seem to be imminent (this year hopefully).
If you're in it for a short term gain, then you've missed the boat for the last round (maybe Nov 13?); but there's still speculation activity in the stock right now (until a deal announcement)
But unless MnG is a scam and we've all been bamboozled, I don't see how it's going to "shrivel and die". It's just going to take longer until the industry accepts it. It's also less of a gamble now than it was 12 months ago.
Anyway, that's my long term stance - it seems a lot of timeframes I'm reading here are "I have to make my money in 5 trading days or ADO is a scam". I mean, you're better off buying lotto.
It would be more worthwhile and interesting, for example, to hear from some disappointed mid-term holders who have sold out and why they have done so. (though I think most are sitting pretty)
ADO Price at posting:
23.5¢ Sentiment: LT Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)